Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 92.21
Day High 93.40
Open:92.46
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports+

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

EHO360 Expands Its Executive Leadership Team With an Emphasis on Hospice
- PR Newswire - PRF - Tue Jul 7, 8:05AM CDT
PR Newswire - PRF - CMTX
Tue Jul 7, 8:05AM CDT
, /PRNewswire/ --  is an experienced national with a deep understanding of the hospice system with hospice provider clients across the country. To expand its reach within the hospice sector, EHO360 welcomes as its new Executive Vice President of Hospice PBM Services.
Wearable Devices Offer Patients More Freedom With Smartphone Implementation
- PR Newswire - PRF - Tue Jul 7, 8:00AM CDT
PR Newswire - PRF - CMTX
Tue Jul 7, 8:00AM CDT
, /PRNewswire/ -- Wearable devices have now become one of the fastest developing segments of the technology and medical technology industries. Wearable devices were designed to track real time data on various activities of its user and can be worn on the body with ease. Generally, these devices include analog-watches, smartwatches, glasses, fitness trackers and others. More recently, synchronization of such devices with smartphones has become an evolving technology with a numerous new features being incorporated into the devices. This increase of diverse applications is a major driver for this market's growth. Furthermore, the implementation of the Internet of Things (IoT) that is used for the development of new features among smartwatches has created an essential transformation in the watch industry. Overall, according to Knowledge Sourcing Intelligence LLP, the wearable devices market is projected to grow at a CAGR of 21.63% to reach by 2025, from in 2019. Nemaura Medical, Inc. (NASDAQ: NMRD), Abbott Laboratories (NYSE: ABT), Medtronic plc (NYSE: MDT), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Livongo Health, Inc. (NASDAQ: LVGO) 
Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX
- GlobeNewswire - Mon Jul 6, 6:08PM CDT
GlobeNewswire - CMTX
Mon Jul 6, 6:08PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(NASDAQ: CODX) and certain of its officers. The class action, filed in United States District Court for the District of Utah, Central Division, and indexed under 20-cv-00481, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired Co-Diagnostics securities between February 25, 2020, and May 15, 2020, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 86.16 +8.37% increase
on 06/25/20
Period Open:89.86
Price movement based on the high, low and last over the given period.
93.97 -0.63% decrease
on 07/06/20
+3.23 (+3.91%) increase
since 06/05/20
3-Month 81.05 +15.21% increase
on 04/08/20
Period Open:81.93
Price movement based on the high, low and last over the given period.
100.00 -6.63% decrease
on 04/20/20
+11.16 (+13.97%) increase
since 04/07/20
52-Week 61.61 +51.56% increase
on 03/23/20
Period Open:85.42
Price movement based on the high, low and last over the given period.
100.00 -6.63% decrease
on 04/20/20
+7.67 (+9.31%) increase
since 07/05/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies